SMAP-29

General Information


DRACP ID  DRACP00001

Peptide Name   SMAP-29

Sequence  RGLRRLGRKIAHGVKKYGPTVLRIIRIA

Sequence Length  28

UniProt ID  Not available

PubChem CID  16130512 

Origin  Ovis aries

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=30 µM MTT assay 2 days 2

Hemolytic Activity  Human erythrocytes (4% Hemolysis=4 µM; 19% Hemolysis=20 µM; 67% Hemolysis=80 µM; 50% Hemolysis=86 µM; 10% Hemolysis=6.0 µm) ; Sheep erythrocytes (3% Hemolysis=80 µM)

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50=16 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00001

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C144H257N51O31

Absent amino acids  CDEFMNQSW

Common amino acids  R

Mass  368073

Pl  12.81

Basic residues  10

Acidic residues  0

Hydrophobic residues  11

Net charge  10

Boman Index  -6364

Hydrophobicity  -20.36

Aliphatic Index  125.36

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  55.19

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 10601638

Title  SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes

Doi 10.1016/s0014-5793(99)01600-2

Year  1999

Literature 2

Pubmed ID 24221355

Title  Bacterial killing mechanism of sheep myeloid antimicrobial peptide-18 (SMAP-18) and its Trp-substituted analog with improved cell selectivity and reduced mammalian cell toxicity

Doi 10.1007/s00726-013-1616-8

Year  2014

Literature 3

Pubmed ID 26795535

Title  The stereochemical effect of SMAP-29 and SMAP-18 on bacterial selectivity, membrane interaction and anti-inflammatory activity

Doi 10.1007/s00726-016-2170-y

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRAMP ID  DRAMP02912

DBAASP ID  1485

DRACP is developed by Dr.Zheng's team.